News

HIV prevention drug lenacapavir approved by FDA as twice-yearly injection
Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...
FDA Approves Powerful Twice-Yearly Treatment to Prevent HIV
Gilead’s Yeztugo will offer an alternative to treatments such as daily pills and every-other-month injections.
FDA offers speedier approvals to drug companies aligning with 'national priorities'
On Tuesday, the U.S. Food and Drug Administration announced a new initiative to offer expedited reviews for new medicines, an ...
FDA’s removal of Ozempic, Wegovy from drug shortage list upheld
A federal judge on Wednesday ruled that the Food and Drug Administration’s (FDA) decision to remove popular GLP-1s from its drug shortage list, ending the sale of compounded versions of the ...
Agence France-Presse on MSN5m
US approves Gilead's twice-yearly injection to prevent HIV
The US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV -- a move ...
FDA announces sweeping changes to speed up the drug review process
An FDA pilot program, known as the Commissioner’s Priority Voucher program, could drastically change the way pharmaceutical ...
Little Remedies Honey Cough Syrup recalled over safety concerns
The recall affects 4 oz. bottles of the natural cough syrup distributed across the United States between December 2022 and ...
STAT48mOpinion
Following second patient death, Duchenne muscular dystrophy families deserve answers about Elevidys
Duchenne muscular dystrophy families are sharing stories about Elevidys complications on social media. But they aren’t ...
FDA approves the world’s only twice-a-year shot to prevent HIV
The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday. It’s the first step in an anticipated global rollout that could protect ...